Article
21 Oct 2025
California Enacts New Requirements And Restrictions For Health Care Transactions
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
27 May 2025
Executive Order Seeks Most-Favored-Nation Drug Pricing And HHS Announces Price Targets
Article
30 Apr 2025
Arkansas Takes Aim At PBM Ownership Of Retail Pharmacies
Article
28 Feb 2025
Federal Court Limits Scope Of California's AB 824 Governing Reverse Payment Settlement Agreements
Article
06 Jan 2025
Only Drugs Allowed: Federal Circuit Affirms Order To Delist Device Patents From The Orange Book
Article
01 Jul 2024
The FTC Strikes Out: Drug Manufacturers Refuse To Play Ball And Delist Orange Book Patents In Response To FTC Warning Letters
Article
30 Apr 2024
Red Alert On The Orange Book: The FTC Continues To Crack Down On Improperly Listed Drug Patents
Article
22 Apr 2024
Maryland And Colorado Say The Price Isn't Right: State Drug Affordability Review Boards Seek Drug Upper Payment Limits
Article
19 Jan 2024
Throwing The (Orange) Book At Pharmaceutical Manufacturers: FTC Challenges Over 100 Drug Product Patents Listed In FDA Publication